RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding RAPT Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 91 | 1 | 92 | +2 |
| Shares | 126.9M | 116.9K | 131.1M | +4.36M (+3.4%) |
| Value | $199.5M | $184.7K | $160.0M | −$39.3M (−19.7%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held RAPT Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AQR Capital Management LLC | 154,327 | $188.3K | 0.00% |
| Nuveen, LLC | 116,925 | $142.6K | 0.00% |
| Checkpoint Capital L.P. | 109,830 | $134.0K | 0.07% |
| Lindbrook Capital, LLC | 27,000 | $32.9K | 0.00% |
| Ieq Capital, LLC | 23,719 | $28.9K | 0.00% |
| Simplicity Wealth,LLC | 20,285 | $24.7K | 0.00% |
| Bank of Montreal | 15,016 | $18.3K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 11,020 | $13.4K | 0.00% |
| Two Sigma Securities, LLC | 10,584 | $12.9K | 0.00% |
| Royal Bank of Canada | 3,670 | $4.00K | 0.00% |
| Coldstream Capital Management Inc | 505 | $617 | 0.00% |
| Rise Advisors, LLC | 435 | $531 | 0.00% |
| Hughes Financial Services, LLC | 327 | $383 | 0.00% |
| True Wealth Design, LLC | 280 | $342 | 0.00% |
| CoreCap Advisors, LLC | 226 | $276 | 0.00% |
| Simplex Trading, LLC | 255 | $0 | 0.00% |
| Avion Wealth | 469 | $0 | 0.00% |
Sold out (15)
Institutions that held RAPT Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Affinity Asset Advisors, LLC | 1,000,000 | $1.58M |
| Kingdon Capital Management, L.L.C. | 575,000 | $908.5K |
| Cormorant Asset Management, LP | 200,000 | $316.0K |
| SG Americas Securities, LLC | 53,244 | $84.0K |
| Shay Capital LLC | 51,300 | $81.1K |
| Group One Trading, L.P. | 49,011 | $77.4K |
| Algert Global LLC | 47,483 | $75.0K |
| UBS Oconnor LLC | 40,000 | $63.2K |
| Jane Street Group, LLC | 36,694 | $58.0K |
| Engineers Gate Manager LP | 16,635 | $26.3K |
| Picton Mahoney Asset Management | 16,175 | $26.0K |
| Ethic Inc. | 11,794 | $18.6K |
| Dimension Capital Management LLC | 10,507 | $16.6K |
| Massmutual Trust Co FSB | 236 | $373 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 125 | $198 |
Not filed for Q1 2025 yet (1)
Institutions that held RAPT Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 116,925 | $184.7K |